Oral contraceptives typically have little impact on libido
For most women, oral contraceptives do not affect libido, but health care providers should be aware that some women may experience negative effects on sexual function, according to a study published online July 12 in The Journal of Sexual Medicine.
(HealthDay) -- For most women, oral contraceptives do not affect libido, but health care providers should be aware that some women may experience negative effects on sexual function, according to a study published online July 12 in The Journal of Sexual Medicine.
Lara J. Burrows, M.D., from Georgetown University in Washington D.C., and colleagues searched and reviewed the literature to investigate the effects of hormonal contraceptives on sexual function in women.
The researchers found that, while side effects such as breast tenderness and weight gain are well documented, sexual side effects are not as well studied. The majority of the literature pertains to combined oral contraceptives. In the literature, mixed effects on libido are reported, with a small percentage of women experiencing an increase or a decrease, and the majority being unaffected. But, for the individual woman who is negatively affected this can have substantial impact on her quality of life and sexuality.
"Health care providers must be aware that hormonal contraceptives can have negative effects on female sexuality so they may counsel and care for their patients appropriately," Burrows and colleagues conclude.
More information: Abstract
Full Text (subscription or payment may be required)
Journal reference:
Journal of Sexual Medicine
Copyright © 2012 HealthDay. All rights reserved.
-
Hormonal contraceptives associated with higher risk of female sexual dysfunction
May 04, 2010 |
not rated yet |
0
-
Marker helps predict thrombotic risk of hormonal contraceptives
Jun 08, 2012 |
not rated yet |
0
-
Hormonal Contraceptives Have Mixed Success Among Overweight Women
Jul 09, 2010 |
not rated yet |
0
-
IUDs reduce pregnancy rates compared to hormonal contraceptives
Jun 15, 2010 |
not rated yet |
0
-
Contraceptive methods shape women's sexual pleasure and satisfaction
Dec 08, 2008 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
Medications
10 hours ago |
not rated yet |
0
Merck ends development of Parkinson's disease drug
(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.
Medications
May 23, 2013 |
1 / 5 (1) |
0
J&J expects 10-plus new drug applications by 2017
(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...
Medications
May 23, 2013 |
5 / 5 (1) |
0
Experts favor US approval of Merck sleeping pill (Update)
An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.
Medications
May 22, 2013 |
not rated yet |
0
Glaxo, US partnering to develop new antibiotics
GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.
Medications
May 22, 2013 |
not rated yet |
0
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Seniors more likely to crash when driving with pet, study finds
(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.